Recognition of reversible and irreversible myocardial injury by technetium pyrophosphate extraction kinetics

Journal Article · Wed Jul 01 04:00:00 EDT 1987 · J. Thorac. Cardiovasc. Surg.; (United States)

OSTI ID:6215958

Silva, R; Chen, Y F; Sell, T L; Lowe, J E; Jones, R H

The need for a more accurate method of detecting episodes of myocardial ischemia during cardiac operations, particularly during the ischemic arrest interval, prompted us to investigate the usefulness of measuring the active extraction of technetium pyrophosphate in identifying and quantitating ischemic injury. Twenty-four adult mongrel dogs were subjected to cardiopulmonary bypass, and normothermic global ischemia was induced by cross-clamping the proximal aorta. Technetium pyrophosphate (1 mCi) was injected through a standard cardioplegia line with normal saline, simulating administration of cardioplegic solution, upon placement of the aortic cross-clamp (time 0), at 15, 30, 45, and 60 minutes of global ischemia, and with the onset and completion of ischemic contracture. Radioactive counts were recorded over the heart at 1 second intervals, and the extraction fraction and half-time of clearance were calculated. The extraction fraction increased from 0.22 at time 0 to 0.58 at 15 minutes, 0.82 at 30 minutes, 0.85 at 45 minutes, and 0.91 at 60 minutes. The halftime increased from a baseline of 114 seconds (time 0) to a maximum of 321 seconds at 60 minutes of ischemia. The onset and completion of ischemic contracture showed a return toward baseline of both the extraction fraction and halftime of clearance, with an extraction fraction of 0.44 and 0.46 and a halftime of 135 and 133 seconds, respectively. These data clearly show that reversible myocardial injury increased the extraction and reduced the clearance of technetium pyrophosphate and that the magnitude of change related to the extent of injury. The progression to irreversible myocardial injury decreased the active extraction of technetium pyrophosphate. This simple procedure for real-time documentation of myocardial injury promises to provide easily obtainable endpoints of injury for use during cardiac operations in humans.

• Research Organization: Duke Univ. Medical Center, Durham, NC
• OSTI ID: 6215958
• Journal Information: J. Thorac. Cardiovasc. Surg.; (United States), Journal Name: J. Thorac. Cardiovasc. Surg.; (United States) Vol. 94:1; ISSN JTCSA
• Country of Publication: United States
• Language: English

Related Subjects

550600* -- Medicine
550601 -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMALS
BIOLOGICAL HALF-LIFE
BODY
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
CLEARANCE
DISEASES
DOGS
ELEMENTS
HEART
ISCHEMIA
ISOTOPE APPLICATIONS
MAMMALS
MEDICINE
METALS
MUSCLES
MYOCARDIUM
ORGANS
OXYGEN COMPOUNDS
PHOSPHORUS COMPOUNDS
PYROPHOSPHATES
SURGERY
TECHNETIUM
TRACER TECHNIQUES
TRANSITION ELEMENTS
VASCULAR DISEASES
VERTEBRATES